HCmed Innovations Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	25.88	65.83	66.61	123.5	48.49	85.95
Short-Term Investments	210	110	177	-	-	-
Cash & Short-Term Investments	235.88	175.83	243.61	123.5	48.49	85.95
Cash Growth	-	-27.83%	97.26%	154.69%	-43.59%	-
Accounts Receivable	0.41	1.47	0.29	0.38	0.1	5.02
Other Receivables	0.59	0.22	0.05	-	0.04	-
Receivables	0.99	1.7	0.34	0.38	0.13	5.02
Inventory	14.55	5.56	5.91	5.39	11.49	13.17
Prepaid Expenses	3.03	4.28	4.67	2.76	1.01	2.27
Other Current Assets	0.01	0	-	-	0	-
Total Current Assets	254.46	187.36	254.54	132.03	61.13	106.41
Property, Plant & Equipment	94.06	28.72	32.23	14.49	19.58	10.3
Long-Term Investments	-	-	-	-	6.59	1.36
Goodwill	-	-	12.16	35.49	-	-
Other Intangible Assets	0.83	13.9	20.37	22.61	0.05	0.25
Other Long-Term Assets	5.3	16.81	6.79	2.01	1.81	1.44
Total Assets	354.66	246.79	326.08	206.62	89.15	119.76
Accounts Payable	5.43	1.25	0.72	1.24	0	0.62
Accrued Expenses	12.75	17.71	14.59	11.04	9.53	8.87
Current Portion of Leases	10.97	6.71	11.81	2.72	5.74	1.9
Current Unearned Revenue	-	0.95	9.01	-	-	0.09
Other Current Liabilities	6.02	6.12	4.45	5.25	4.35	3.63
Total Current Liabilities	37.12	32.74	40.58	20.25	19.61	15.09
Long-Term Leases	8.17	2.13	4.44	0.88	3.41	0.13
Long-Term Unearned Revenue	-	-	-	-	-	11.86
Long-Term Deferred Tax Liabilities	-	2.6	4.05	4.52	-	-
Other Long-Term Liabilities	-	-	-	-	238.45	238.45
Total Liabilities	87.87	37.48	49.07	25.65	261.47	265.54
Common Stock	327.17	300.34	300.11	244.11	175.31	175.31
Additional Paid-In Capital	610.48	446.76	436.87	230.73	5.69	5.69
Retained Earnings	-671.07	-538.01	-459.79	-293.87	-366.97	-326.78
Comprehensive Income & Other	0.21	0.23	-0.17	-	13.64	-
Shareholders' Equity	266.79	209.31	277.01	180.97	-172.32	-145.78
Total Liabilities & Equity	354.66	246.79	326.08	206.62	89.15	119.76
Total Debt	63.67	8.84	16.25	3.6	9.15	2.02
Net Cash (Debt)	172.21	166.99	227.37	119.9	39.34	83.93
Net Cash Growth	-	-26.55%	89.63%	204.77%	-53.13%	-
Net Cash Per Share	5.47	5.56	8.56	5.55	2.24	4.81
Filing Date Shares Outstanding	32.72	30.03	30.01	24.41	25.63	17.44
Total Common Shares Outstanding	32.72	30.03	30.01	24.41	17.53	17.44
Working Capital	217.34	154.62	213.96	111.78	41.52	91.32
Book Value Per Share	8.15	6.97	9.23	7.41	-9.83	-8.36
Tangible Book Value	265.95	195.41	244.49	122.88	-172.38	-146.03
Tangible Book Value Per Share	8.13	6.51	8.15	5.03	-9.83	-8.37
Machinery	49.59	44.42	34.2	25.59	19.95	13.17
Construction In Progress	-	-	0.55	0.3	-	1.3
Leasehold Improvements	12.74	12.32	12.04	7.2	6.19	5.83

Source: S&P Global Market Intelligence. Standard template. Financial Sources.